Insulin-Like Growth Factor Binding Protein, Acid Labile Subunit (IGFALS) Peptide
Quick Overview for Insulin-Like Growth Factor Binding Protein, Acid Labile Subunit (IGFALS) Peptide (ABIN937255)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DCGCPLKALR DFALQNPSAV PRFVQAICEG DDCQPPAYTY NNITCASPPE
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of IGFALS antibody,
Alternative Names: IGFALS control peptide, IGFALS antibody Blocking Peptide, Anti-IGFALS Blocking Peptide, Insulin-Like Growth Factor Binding Protein Acid Labile Subunit Blocking Peptide, ALS Blocking Peptide -
Purification
- Immunoaffinity chromatography
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- IGFALS (Insulin-Like Growth Factor Binding Protein, Acid Labile Subunit (IGFALS))
-
Background
- The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Three transcript variants encoding two different isoforms have been found for this gene.
-
Molecular Weight
- 63 kDa
Target
-